“Non-criteria” antiphospholipid antibodies add value to antiphospholipid syndrome diagnoses in a large Chinese cohort

BACKGROUND: Despite expansion in the 2006 Sydney antiphospholipid syndrome (APS) classification criteria to include IgG/IgM anti-β2-glycoprotein (aβ2GPI) antibodies in addition to IgG/IgM anti-cardiolipin antibodies (aCL) and lupus anticoagulant (LAC), some individuals with clinical features of APS...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Tingting, Gu, Jieyu, Wan, Liyan, Hu, Qiongyi, Teng, Jialin, Liu, Honglei, Cheng, Xiaobing, Ye, Junna, Su, Yutong, Sun, Yue, Zhou, Jinfeng, Norman, Gary L., Wang, Xuefeng, Yang, Chengde, Shi, Hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7035660/
https://www.ncbi.nlm.nih.gov/pubmed/32085759
http://dx.doi.org/10.1186/s13075-020-2131-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7035660/
https://www.ncbi.nlm.nih.gov/pubmed/32085759
http://dx.doi.org/10.1186/s13075-020-2131-4

Ejemplares similares